| Autor: |
Tian Y; Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China., Fu X; Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China., Li Q; Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China., Wang Y; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China., Fan D; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China., Zhou Q; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China., Kuang W; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China., Shen L; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. |
| Abstrakt: |
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the Transwell cell migration assay data shown in Figs. 3B and 9B were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 18: 5603‑5613, 2018; DOI: 10.3892/mmr.2018.9572]. |
